BioMap Completes $100 Million Series A Financing

(VCBeat) July. 30, 2021 -- Biocomputing platform Baitushengke ("BioMap") today announced the completion of a Series A financing of 100 million dollars, led by GGV Capital, with participation from Baidu, Legend Capital, BlueRun Ventures, Zhenzhi Capital and Xiang He Capital, and the company's founder Robin Li continued to make additional investment. The funds raised will mainly be used for technology research and development and talent introduction.

BioMap is an AI-driven research and development platform focusing on precision medicine that is co-founded by Baidu Corporate's founder/CEO Robin Li and former Baidu Ventures' CEO Wei Liu. The company strives to accelerate the development of new therapeutic and diagnostic products through the integration of novel AI advancements and frontier biotechnologies.

Through advanced computing and biotechnology, BioMap effectively extracts knowledge from multi-omic data, high-throughput validation experiments and drug development experience, and draws maps of disease targets and drug design, which can improve the efficiency of drug development, and ultimately achieve original development of Global First-in-class drugs.

In the future, BioMap will focus on the research of the immune mechanism of tumors, autoimmune diseases and fibrosis diseases.

The team of BioMap points out that to make "AI+ biopharmaceuticals" truly work, AI technology needs to be applied to all aspects of drug discovery. To this end, BioMap is also building its own laboratory, so as to improve the operation efficiency of the industry.

After this round of financing, BioMap will further strengthen the construction of its biocomputing engine, accelerate the research and development in multi-omics technology, high-throughput experimental technology, protein computing technology, high-performance biocomputing technology and other fields, increase the introduction of talent, and promote its first drug R&D pipeline to a new stage.

Founded in 2000, GGV Capital is a global venture capital firm that invests in local founders. As a multi-stage, sector-focused firm, GGV focuses on seed-to-growth stage investments across Consumer/New Retail, Social/Digital & Internet, Enterprise/Cloud and Frontier Tech sectors.

Established in April 2001, Legend Capital is an independent professional Venture Capital firm under Legend Holdings. Legend Capital focuses on early-stage venture capital and expansion-stage growth capital investment. The company is now managing several USD funds and RMB funds with a total AUM of 45 billion yuan.